FDA Inspection
Robert B. Molpus, M.D.Robert B. Molpus, M.D. – FDA Inspection, Apr 3, 2025
Record Details
This FDA Inspection record concerns Robert B. Molpus, M.D., with an inspection on April 3, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a3a7a1cc-83dc-432d-807c-b450bc9d442a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1266065
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Robert B. Molpus, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2026 | Not classified | Florida District Office | Bioresearch Monitoring |
| August 10, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert B. Molpus, M.D.
- FDA Inspection 1333912 - 2026-08-28
- FDA Inspection 1127812 - 2020-08-10
- FDA Inspection 1039869 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.